Cargando…

Proteochemometric modeling in a Bayesian framework

Proteochemometrics (PCM) is an approach for bioactivity predictive modeling which models the relationship between protein and chemical information. Gaussian Processes (GP), based on Bayesian inference, provide the most objective estimation of the uncertainty of the predictions, thus permitting the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cortes-Ciriano, Isidro, van Westen, Gerard JP, Lenselink, Eelke Bart, Murrell, Daniel S, Bender, Andreas, Malliavin, Thérèse
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083135/ https://www.ncbi.nlm.nih.gov/pubmed/25045403 http://dx.doi.org/10.1186/1758-2946-6-35

Ejemplares similares

Applications of proteochemometrics - from species extrapolation to cell line sensitivity modelling
por: Cortes-Ciriano, Isidro, et al.
Publicado: (2015)

Prediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modeling
por: Cortes-Ciriano, Isidro, et al.
Publicado: (2015)

Proteochemometric modelling coupled to in silico target prediction: an integrated approach for the simultaneous prediction of polypharmacology and binding affinity/potency of small molecules
por: Paricharak, Shardul, et al.
Publicado: (2015)

Benchmarking of protein descriptor sets in proteochemometric modeling (part 2): modeling performance of 13 amino acid descriptor sets
por: van Westen, Gerard JP, et al.
Publicado: (2013)

Chemically Aware Model Builder (camb): an R package for property and bioactivity modelling of small molecules
por: Murrell, Daniel S, et al.
Publicado: (2015)

Predicting the binding type of compounds on the 4 adenosine receptors using proteochemometric models
por: van den Hoven, Olaf, et al.
Publicado: (2010)

Towards predictive resistance models for agrochemicals by combining chemical and protein similarity via proteochemometric modelling
por: van Westen, Gerard J. P., et al.
Publicado: (2014)

Improved large-scale prediction of growth inhibition patterns using the NCI60 cancer cell line panel
por: Cortés-Ciriano, Isidro, et al.
Publicado: (2016)

Benchmarking of protein descriptor sets in proteochemometric modeling (part 1): comparative study of 13 amino acid descriptor sets
por: van Westen, Gerard JP, et al.
Publicado: (2013)

Improving the prediction of organism-level toxicity through integration of chemical, protein target and cytotoxicity qHTS data
por: Allen, Chad H. G., et al.
Publicado: (2016)

Significantly Improved HIV Inhibitor Efficacy Prediction Employing Proteochemometric Models Generated From Antivirogram Data
por: van Westen, Gerard J. P., et al.
Publicado: (2013)

Which Compound to Select in Lead Optimization? Prospectively Validated Proteochemometric Models Guide Preclinical Development
por: van Westen, Gerard J. P., et al.
Publicado: (2011)

Proteochemometric Modeling Identifies Chemically Diverse Norepinephrine Transporter Inhibitors
por: Bongers, Brandon J., et al.
Publicado: (2023)

Identification of Allosteric Modulators of Metabotropic Glutamate 7 Receptor Using Proteochemometric Modeling
por: Tresadern, Gary, et al.
Publicado: (2017)

Linking the Resource Description Framework to cheminformatics and proteochemometrics
por: Willighagen, Egon L, et al.
Publicado: (2011)

Identification of novel small molecule inhibitors for solute carrier SGLT1 using proteochemometric modeling
por: Burggraaff, Lindsey, et al.
Publicado: (2019)

Proteochemometric modeling of HIV protease susceptibility
por: Lapins, Maris, et al.
Publicado: (2008)

Unsupervised Representation Learning for Proteochemometric Modeling
por: Kim, Paul T., et al.
Publicado: (2021)

QSAR-derived affinity fingerprints (part 2): modeling performance for potency prediction
por: Cortés-Ciriano, Isidro, et al.
Publicado: (2020)

KekuleScope: prediction of cancer cell line sensitivity and compound potency using convolutional neural networks trained on compound images
por: Cortés-Ciriano, Isidro, et al.
Publicado: (2019)

Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 2: a discussion of chemical and biological data
por: Bender, Andreas, et al.
Publicado: (2021)

Screening of selective histone deacetylase inhibitors by proteochemometric modeling
por: Wu, Dingfeng, et al.
Publicado: (2012)

Origin of aromatase inhibitory activity via proteochemometric modeling
por: Simeon, Saw, et al.
Publicado: (2016)

Large-Scale Modeling of Sparse Protein Kinase Activity Data
por: Luukkonen, Sohvi, et al.
Publicado: (2023)

3DDPDs: describing protein dynamics for proteochemometric bioactivity prediction. A case for (mutant) G protein-coupled receptors
por: Gorostiola González, Marina, et al.
Publicado: (2023)

A semi-supervised learning framework for quantitative structure–activity regression modelling
por: Watson, Oliver, et al.
Publicado: (2020)

Unbiased descriptor and parameter selection confirms the potential of proteochemometric modelling
por: Freyhult, Eva, et al.
Publicado: (2005)

Identification of binding sites and favorable ligand binding moieties by virtual screening and self-organizing map analysis
por: Harigua-Souiai, Emna, et al.
Publicado: (2015)

Application of fourier transform and proteochemometrics principles to protein engineering
por: Cadet, Frédéric, et al.
Publicado: (2018)

Proteochemometric Method for pIC50 Prediction of Flaviviridae
por: Singh, Divye, et al.
Publicado: (2022)

Multitask machine learning models for predicting lipophilicity (logP) in the SAMPL7 challenge
por: Lenselink, Eelke B., et al.
Publicado: (2021)

A Unified Proteochemometric Model for Prediction of Inhibition of Cytochrome P450 Isoforms
por: Lapins, Maris, et al.
Publicado: (2013)

Balancing Data on Deep Learning-Based Proteochemometric Activity Classification
por: Lopez-del Rio, Angela, et al.
Publicado: (2021)

Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set
por: Lenselink, Eelke B., et al.
Publicado: (2017)

Experimental validation of in silico target predictions on synergistic protein targets
por: Cortes-Ciriano, Isidro, et al.
Publicado: (2013)

Drug Discovery Maps, a Machine Learning Model That Visualizes and Predicts Kinome–Inhibitor Interaction Landscapes
por: Janssen, Antonius P. A., et al.
Publicado: (2018)

Proteochemometric Modeling of the Susceptibility of Mutated Variants of the HIV-1 Virus to Reverse Transcriptase Inhibitors
por: Junaid, Muhammad, et al.
Publicado: (2010)

An Analysis of Proteochemometric and Conformal Prediction Machine Learning Protein-Ligand Binding Affinity Models
por: Parks, Conor, et al.
Publicado: (2020)

Bioalerts: a python library for the derivation of structural alerts from bioactivity and toxicity data sets
por: Cortes-Ciriano, Isidro
Publicado: (2016)

QSAR-derived affinity fingerprints (part 1): fingerprint construction and modeling performance for similarity searching, bioactivity classification and scaffold hopping
por: Škuta, C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4vnl4dpbc8q4s2f30ipbpotr0u